MII IG Kerndatensatz-Modul Seltene Erkrankungen
2027.0.0-ballot -
Germany
This page is part of the MII Implementation Guide Seltene Erkrankungen (v2027.0.0-ballot: 2027 Ballot 1) based on FHIR (HL7® FHIR® Standard) R4. This is the current published version in its permanent home (it will always be available at this URL). For a full list of available versions, see the Directory of published versions
| Offizielle URL: https://www.medizininformatik-initiative.de/fhir/ext/modul-seltene/ValueSet/mii-vs-seltene-nbs-acylcarnitine-dbs | Version: 2027.0.0-ballot | |||
| Active Stand: 2026-09-14 | Maschinenlesbarer Name: MII_VS_Seltene_NBS_Acylcarnitine_DBS | |||
Acylcarnitin- und Carnitin-Analyte in Trockenblut (dried blood spot) — die Messgrößen des MS/MS-Acylcarnitinprofils im Neugeborenenscreening (Fettsäureoxidationsstörungen, Organoazidopathien, Carnitinzyklusdefekte). Abgeleitet aus der LOINC-SNOMED-Ontologie und deshalb NICHT vollständig gegenüber LOINC: enthalten ist der nach SNOMED gemappte Teil. Für die lückenlose Menge siehe mii-vs-seltene-nbs-dbs-all.
References
This value set is not used here; it may be used elsewhere (e.g. specifications and/or implementations that use this content)
Profiles: CRMI Shareable ValueSet, CRMI Publishable ValueSet
http://loinc.org version Not Stated (use latest from terminology server)| Code | Display |
| 50102-3 | 3-Hydroxybutyrylcarnitine (C4-OH) [Moles/volume] in DBS |
| 53189-7 | 3-Hydroxydodecanoylcarnitine (C12-OH) [Moles/volume] in DBS |
| 53173-1 | 3-Hydroxyhexanoylcarnitine (C6-OH) [Moles/volume] in DBS |
| 50106-4 | 3-Hydroxyisovalerylcarnitine (C5-OH) [Moles/volume] in DBS |
| 53171-5 | 3-Hydroxyisovalerylcarnitine (C5-OH)/Carnitine.free (C0) [Molar ratio] in DBS |
| 53172-3 | 3-Hydroxyisovalerylcarnitine (C5-OH)/Octanoylcarnitine (C8) [Molar ratio] in DBS |
| 50109-8 | 3-Hydroxylinoleoylcarnitine (C18:2-OH) [Moles/volume] in DBS |
| 50113-0 | 3-Hydroxyoleoylcarnitine (C18:1-OH) [Moles/volume] in DBS |
| 50121-3 | 3-Hydroxypalmitoleylcarnitine (C16:1-OH) [Moles/volume] in DBS |
| 50125-4 | 3-Hydroxypalmitoylcarnitine (C16-OH) [Moles/volume] in DBS |
| 53201-0 | 3-Hydroxypalmitoylcarnitine (C16-OH)/Palmitoylcarnitine (C16) [Molar ratio] in DBS |
| 50132-0 | 3-Hydroxystearoylcarnitine (C18-OH) [Moles/volume] in DBS |
| 53196-2 | 3-Hydroxytetradecadienoylcarnitine (C14:2-OH) [Moles/volume] in DBS |
| 50281-5 | 3-Hydroxytetradecanoylcarnitine (C14-OH) [Moles/volume] in DBS |
| 53197-0 | 3-Hydroxytetradecenoylcarnitine (C14:1-OH) [Moles/volume] in DBS |
| 50157-7 | Acetylcarnitine (C2) [Moles/volume] in DBS |
| 53237-4 | Acrylylcarnitine (C3:1) [Moles/volume] in DBS |
| 38474-3 | Acylcarnitine [Moles/volume] in DBS |
| 43717-8 | Acylcarnitine [Presence] in DBS |
| 74628-9 | Adipoylcarnitine (C6-DC) [Moles/volume] in DBS |
| 53613-6 | Benzoylcarnitine (BzCn) [Moles/volume] in DBS |
| 53065-9 | Butyrylcarnitine (C4) [Moles/volume] in DBS |
| 53180-6 | Decadienoylcarnitine (C10:2) [Moles/volume] in DBS |
| 45197-1 | Decanoylcarnitine (C10) [Moles/volume] in DBS |
| 45198-9 | Decenoylcarnitine (C10:1) [Moles/volume] in DBS |
| 53214-3 | Dicarboxydodecanoylcarnitine (C12-DC) [Moles/volume] in DBS |
| 53213-5 | Dicarboxydodecenoylcarnitine (C12:1-DC) [Moles/volume] in DBS |
| 53218-4 | Dicarboxypalmitoylcarnitine (C16-DC) [Moles/volume] in DBS |
| 53220-0 | Dicarboxystearoylcarnitine (C18-DC) [Moles/volume] in DBS |
| 53219-2 | Dicarboxyoleylcarnitine (C18:1-DC) [Moles/volume] in DBS |
| 53216-8 | Dicarboxytetradecanoylcarnitine (C14-DC) [Moles/volume] in DBS |
| 53215-0 | Dicarboxytetradecenoylcarnitine (C14:1-DC) [Moles/volume] in DBS |
| 45199-7 | Dodecanoylcarnitine (C12) [Moles/volume] in DBS |
| 45200-3 | Dodecenoylcarnitine (C12:1) [Moles/volume] in DBS |
| 53462-8 | Eicosanoylcarnitine (C20) [Moles/volume] in DBS |
| 45207-8 | Glutarylcarnitine (C5-DC) [Moles/volume] in DBS |
| 88016-1 | Glutarylcarnitine (C5-DC)/Acetylcarnitine (C2) [Molar ratio] in DBS |
| 75225-3 | Glutarylcarnitine (C5-DC)/Carnitine (C0) [Molar ratio] in DBS |
| 75216-2 | Glutarylcarnitine (C5-DC)/Malonylcarnitine (C3-DC) [Molar ratio] in DBS |
| 75267-5 | Glutarylcarnitine (C5-DC)/Palmitoylcarnitine (C16) [Molar ratio] in DBS |
| 88017-9 | Glutarylcarnitine (C5-DC)/Propionylcarnitine (C3) [Molar ratio] in DBS |
| 53204-4 | Heptanoylcarnitine (C7) [Moles/volume] in DBS |
| 45211-0 | Hexanoylcarnitine (C6) [Moles/volume] in DBS |
| 45213-6 | Isobutyrylcarnitine (C4) [Moles/volume] in DBS |
| 42920-9 | Isovalerylcarnitine (C5) [Moles/volume] in DBS |
| 45217-7 | Linoleoylcarnitine (C18:2) [Moles/volume] in DBS |
| 54462-7 | Malonylcarnitine (C3-DC) [Moles/volume] in DBS |
| 75212-1 | Malonylcarnitine (C3-DC)/Decanoylcarnitine (C10) [Molar ratio] in DBS |
| 45222-7 | Methylmalonylcarnitine (C4-DC) [Moles/volume] in DBS |
| 53181-4 | Methylmalonylcarnitine (C4-DC)/3-Hydroxyisovalerylcarnitine (C5-OH) [Molar ratio] in DBS |
| 53207-7 | Nonanoylcarnitine (C9) [Moles/volume] in DBS |
| 53175-6 | Octanoylcarnitine (C8) [Moles/volume] in DBS |
| 53176-4 | Octanoylcarnitine (C8)/Acetylcarnitine (C2) [Molar ratio] in DBS |
| 53177-2 | Octanoylcarnitine (C8)/Decanoylcarnitine (C10) [Molar ratio] in DBS |
| 88014-6 | Octanoylcarnitine (C8)/Carnitine.free (C0) [Molar ratio] in DBS |
| 53174-9 | Octenoylcarnitine (C8:1) [Moles/volume] in DBS |
| 53202-8 | Oleoylcarnitine (C18:1) [Moles/volume] in DBS |
| 53199-6 | Palmitoylcarnitine (C16) [Moles/volume] in DBS |
| 88015-3 | Palmitoylcarnitine (C16)/Acetylcarnitine (C2) [Molar ratio] in DBS |
| 88024-5 | Palmitoylcarnitine (C16)/Carnitine.free (C0) [Molar ratio] in DBS |
| 54475-9 | Pimeloylcarnitine (C7-DC) [Moles/volume] in DBS |
| 53160-8 | Propionylcarnitine (C3) [Moles/volume] in DBS |
| 53163-2 | Propionylcarnitine (C3)/Acetylcarnitine (C2) [Molar ratio] in DBS |
| 53162-4 | Propionylcarnitine (C3)/Carnitine.free (C0) [Molar ratio] in DBS |
| 53164-0 | Propionylcarnitine (C3)/Palmitoylcarnitine (C16) [Molar ratio] in DBS |
| 53161-6 | Propionylcarnitine (C3)/Methionine [Molar ratio] in DBS |
| 53241-6 | Stearoylcarnitine (C18) [Moles/volume] in DBS |
| 53400-8 | Stearoylcarnitine (C18)/Propionylcarnitine (C3) [Molar ratio] in DBS |
| 53210-1 | Suberylcarnitine (C8-DC) [Moles/volume] in DBS |
| 53190-5 | Tetradecadienoylcarnitine (C14:2) [Moles/volume] in DBS |
| 53192-1 | Tetradecanoylcarnitine (C14) [Moles/volume] in DBS |
| 53191-3 | Tetradecenoylcarnitine (C14:1) [Moles/volume] in DBS |
| 53193-9 | Tetradecenoylcarnitine (C14:1)/Acetylcarnitine (C2) [Molar ratio] in DBS |
| 53194-7 | Tetradecenoylcarnitine (C14:1)/Dodecenoylcarnitine (C12:1) [Molar ratio] in DBS |
| 88025-2 | Tetradecenoylcarnitine (C14:1)/Carnitine.free (C0) [Molar ratio] in DBS |
| 53195-4 | Tetradecenoylcarnitine (C14:1)/Palmitoylcarnitine (C16) [Molar ratio] in DBS |
| 70159-9 | Tetradecenoylcarnitine (C14:1)/Tetradecanoylcarnitine (C14) [Molar ratio] in DBS |
| 53170-7 | Tiglylcarnitine (C5:1) [Moles/volume] in DBS |
Expansion from 127.0.0.1 based on Loinc v2.83
This value set contains 78 concepts
| System | Code | Display (de) | JSON | XML |
http://loinc.org | 50102-3 | |||
http://loinc.org | 53189-7 | |||
http://loinc.org | 53173-1 | |||
http://loinc.org | 50106-4 | |||
http://loinc.org | 53171-5 | |||
http://loinc.org | 53172-3 | |||
http://loinc.org | 50109-8 | |||
http://loinc.org | 50113-0 | |||
http://loinc.org | 50121-3 | |||
http://loinc.org | 50125-4 | |||
http://loinc.org | 53201-0 | |||
http://loinc.org | 50132-0 | |||
http://loinc.org | 53196-2 | |||
http://loinc.org | 50281-5 | |||
http://loinc.org | 53197-0 | |||
http://loinc.org | 50157-7 | |||
http://loinc.org | 53237-4 | |||
http://loinc.org | 38474-3 | |||
http://loinc.org | 43717-8 | |||
http://loinc.org | 74628-9 | |||
http://loinc.org | 53613-6 | |||
http://loinc.org | 53065-9 | |||
http://loinc.org | 53180-6 | |||
http://loinc.org | 45197-1 | |||
http://loinc.org | 45198-9 | |||
http://loinc.org | 53214-3 | |||
http://loinc.org | 53213-5 | |||
http://loinc.org | 53218-4 | |||
http://loinc.org | 53220-0 | |||
http://loinc.org | 53219-2 | |||
http://loinc.org | 53216-8 | |||
http://loinc.org | 53215-0 | |||
http://loinc.org | 45199-7 | |||
http://loinc.org | 45200-3 | |||
http://loinc.org | 53462-8 | |||
http://loinc.org | 45207-8 | |||
http://loinc.org | 88016-1 | |||
http://loinc.org | 75225-3 | |||
http://loinc.org | 75216-2 | |||
http://loinc.org | 75267-5 | |||
http://loinc.org | 88017-9 | |||
http://loinc.org | 53204-4 | |||
http://loinc.org | 45211-0 | |||
http://loinc.org | 45213-6 | |||
http://loinc.org | 42920-9 | |||
http://loinc.org | 45217-7 | |||
http://loinc.org | 54462-7 | |||
http://loinc.org | 75212-1 | |||
http://loinc.org | 45222-7 | |||
http://loinc.org | 53181-4 | |||
http://loinc.org | 53207-7 | |||
http://loinc.org | 53175-6 | |||
http://loinc.org | 53176-4 | |||
http://loinc.org | 53177-2 | |||
http://loinc.org | 88014-6 | |||
http://loinc.org | 53174-9 | |||
http://loinc.org | 53202-8 | |||
http://loinc.org | 53199-6 | |||
http://loinc.org | 88015-3 | |||
http://loinc.org | 88024-5 | |||
http://loinc.org | 54475-9 | |||
http://loinc.org | 53160-8 | |||
http://loinc.org | 53163-2 | |||
http://loinc.org | 53162-4 | |||
http://loinc.org | 53164-0 | |||
http://loinc.org | 53161-6 | |||
http://loinc.org | 53241-6 | |||
http://loinc.org | 53400-8 | |||
http://loinc.org | 53210-1 | |||
http://loinc.org | 53190-5 | |||
http://loinc.org | 53192-1 | |||
http://loinc.org | 53191-3 | |||
http://loinc.org | 53193-9 | |||
http://loinc.org | 53194-7 | |||
http://loinc.org | 88025-2 | |||
http://loinc.org | 53195-4 | |||
http://loinc.org | 70159-9 | |||
http://loinc.org | 53170-7 |